Stereotaxis, Inc. (STXS)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch STXS
See up to 3 months of STXS. The 7-day demo opens the 1M and 3M ranges and puts STXS on your watchlist.
Start 7-day demoLatest STXS insider trades
- Paul J. Isaac - DirectorOpen-market purchase$22K
- Paul J. Isaac - DirectorOpen-market purchase$45K
Nachum Shamir - Director
About Stereotaxis, Inc. (STXS)
The SEC lists Stereotaxis, Inc. under CIK 0001289340, in electromedical and electrotherapeutic apparatus. It is grouped with Health Care companies on this site.
STXS Form 4 activity by transaction type, last 90 days
No Form 4 activity for STXS in the last 90 days.
STXS insider transactions (Form 4)
2221 Form 4 filings on record, the earliest from Apr 8, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Nachum Shamir - Director | Grant or award | Common Stock | 43,103 footnote F1 | $0.00 | - | |
| ||||||
 David Benfer - Director | Grant or award | Common Stock | 43,103 footnote F1 | $0.00 | - | |
| ||||||
 Ross B. Levin - Director | Grant or award | Common Stock | 43,103 footnote F1 | $0.00 | - | |
| ||||||
 Myriam Curet - Director | Grant or award | Common Stock | 43,103 footnote F1 | $0.00 | - | |
| ||||||
| Nathan Fischel - Director | Grant or award | Common Stock | 43,103 footnote F1 | $0.00 | - | |
| ||||||
 Arun Swarup Menawat - Director | Grant or award | Common Stock | 43,103 footnote F1 | $0.00 | - | |
| ||||||
| Kimberly R. Peery - Officer | Grant or award | Stock Options -Right to Buy | 40,000 | $0.00 | - | |
| Arun Swarup Menawat - Director | Grant or award | Common Stock | 46,948 | $0.00 | - | |
| David Benfer - Director | Grant or award | Common Stock | 46,948 | $0.00 | - | |
| Myriam Curet - Director | Grant or award | Common Stock | 46,948 | $0.00 | - | |
| Nathan Fischel - Director | Grant or award | Common Stock | 46,948 | $0.00 | - | |
| Ross B. Levin - Director | Grant or award | Common Stock | 46,948 | $0.00 | - | |
| Nachum Shamir - Director | Grant or award | Common Stock | 46,948 | $0.00 | - | |
| Paul J. Isaac - Director | Open-market purchase | Common Stock | 10,000 | $2.18 | $22K | |
| Paul J. Isaac - Director | Open-market purchase | Common Stock | 20,000 | $2.24 | $45K | |
| Arun Swarup Menawat - Director | Grant or award | Common Stock | 43,668 | $0.00 | - | |
| Ross B. Levin - Director | Grant or award | Common Stock | 43,668 | $0.00 | - | |
| Nathan Fischel - Director | Grant or award | Common Stock | 43,668 | $0.00 | - | |
| David Benfer - Director | Grant or award | Common Stock | 43,668 | $0.00 | - | |
| Myriam Curet - Director | Grant or award | Common Stock | 43,668 | $0.00 | - | |
| Nachum Shamir - Director | Grant or award | Common Stock | 43,668 | $0.00 | - | |
| Kimberly R. Peery - Officer | Grant or award | Stock Options -Right to Buy | 50,000 | $0.00 | - | |
Item 2.02, 9.01
Item 8.01, 9.01
Item 3.02, 7.01, 8.01, 9.01
Item 5.07
STXS insider trading FAQ
What is the latest insider trade for STXS?
Stereotaxis, Inc. (STXS) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-07-01. The full record for STXS runs to 21 Form 4 filings, the earliest from 2025-04-08. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying STXS stock?
No insider purchases of STXS were filed in the last 90 days. 2 purchases are on record for this company.
How many insiders are selling STXS stock?
No insider sales of STXS were filed in the last 90 days.
Where can I see STXS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects STXS Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Nachum Shamir view on EDGAR
- - David Benfer view on EDGAR
- - Ross B. Levin view on EDGAR
- - Myriam Curet view on EDGAR
- - Nathan Fischel view on EDGAR
- - Arun Swarup Menawat view on EDGAR
- - Kimberly R. Peery view on EDGAR
- - Arun Swarup Menawat view on EDGAR
- - David Benfer view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where STXS's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow STXS with a 7-day demo
- STXS on your watchlist
- Every STXS Form 4 filing on record
- Up to 3 months of STXS price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
